Cardiovascular Stents: a Review of Past, Current, and Emerging Devices

Total Page:16

File Type:pdf, Size:1020Kb

Cardiovascular Stents: a Review of Past, Current, and Emerging Devices materials Review Cardiovascular Stents: A Review of Past, Current, and Emerging Devices 1,2 3 4,5, Alexandru Scafa Udris, te , Adelina-Gabriela Niculescu , Alexandru Mihai Grumezescu * and Elisabeta Bădilă 1,6 1 Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania; [email protected] (A.S.U.); [email protected] (E.B.) 2 Cardiology Department, Clinical Emergency Hospital Bucharest, 014461 Bucharest, Romania 3 Faculty of Engineering in Foreign Languages, University Politehnica of Bucharest, 060042 Bucharest, Romania; [email protected] 4 Faculty of Applied Chemistry and Materials Science, University Politehnica of Bucharest, 060042 Bucharest, Romania 5 Research Institute of the University of Bucharest—ICUB, University of Bucharest, 050657 Bucharest, Romania 6 Internal Medicine Department, Clinical Emergency Hospital Bucharest, 014461 Bucharest, Romania * Correspondence: [email protected]; Tel.: +40-21-402-3997 Abstract: One of the leading causes of morbidity and mortality worldwide is coronary artery disease, a condition characterized by the narrowing of the artery due to plaque deposits. The standard of care for treating this disease is the introduction of a stent at the lesion site. This life-saving tubular Citation: Scafa Udris, te, A.; Niculescu, A.-G.; Grumezescu, A.M.; device ensures vessel support, keeping the blood-flow path open so that the cardiac muscle receives B˘adil˘a,E. Cardiovascular Stents: A its vital nutrients and oxygen supply. Several generations of stents have been iteratively developed Review of Past, Current, and towards improving patient outcomes and diminishing adverse side effects following the implanting Emerging Devices. Materials 2021, 14, procedure. Moving from bare-metal stents to drug-eluting stents, and recently reaching bioresorbable 2498. https://doi.org/10.3390/ stents, this research field is under continuous development. To keep up with how stent technology ma14102498 has advanced in the past few decades, this paper reviews the evolution of these devices, focusing on how they can be further optimized towards creating an ideal vascular scaffold. Academic Editors: Rafael Antonio Balart Gimeno, Teodomiro Keywords: cardiovascular stents; stent platform materials; stent optimization; surface functionalization Boronat Vitoria, Joaquim Ciurana Gay, Arantxa Eceiza Mendiguren and Luís Jesús Quiles Carrillo 1. Introduction Received: 7 April 2021 Cardiovascular diseases have become an increasingly serious threat to human life; they Accepted: 10 May 2021 are the leading cause of hospitalization and death globally [1–5]. Coronary artery disease Published: 12 May 2021 (CAD), in particular, is the third most common cause of mortality worldwide, imposing a major health and economic burden on most developed nations [6–11]. CAD is characterized Publisher’s Note: MDPI stays neutral by the narrowing of the artery due to plaque deposits beneath the endothelium. Cells, fats, with regard to jurisdictional claims in calcium, cellular debris, and other substances may accumulate in these deposits, starting published maps and institutional affil- a cascade of events—diminished blood vessel artery lumen, restricted blood flow, and iations. inadequate nutrients and oxygen supply to the cardiac muscle—that can eventually cause myocardial infarction or transient cerebral ischemic attacks and stroke [12–17]. To restore normal blood flow and avoid the other critical consequences of vessel narrowing, special devices called stents can be inserted into the affected vessel using Copyright: © 2021 by the authors. fluoroscopic and/or endoscopic guidance [13,14]. This procedure is minimally invasive Licensee MDPI, Basel, Switzerland. compared to open cardiac surgery and is associated with lower mortality and morbidity in This article is an open access article the long term and better outcomes in critically ill patients in the short term [15]. distributed under the terms and Therefore, cardiovascular stents are life-saving devices, rightfully included in the top conditions of the Creative Commons ten medical breakthroughs of our century [18]. From a constructive point of view, stents Attribution (CC BY) license (https:// are small, complex, cylindrically shaped hollow structures formed into a sequential ring creativecommons.org/licenses/by/ construction comprising a series of struts and connecting elements [13,15,19]. The way that 4.0/). Materials 2021, 14, 2498. https://doi.org/10.3390/ma14102498 https://www.mdpi.com/journal/materials Materials 2021, 14, x FOR PEER REVIEW 2 of 23 Therefore, cardiovascular stents are life-saving devices, rightfully included in the top ten medical breakthroughs of our century [18]. From a constructive point of view, stents Materials 2021, 14, 2498 2 of 22 are small, complex, cylindrically shaped hollow structures formed into a sequential ring construction comprising a series of struts and connecting elements [13,15,19]. The way that stents work relies on their design, which helps keep the path of human arteries stentsthrough work the reliesbody open on their [20,21]. design, which helps keep the path of human arteries through the bodyInitially, open bare-metal [20,21]. stents were used as a bail-out intervention scenario in the case of abruptInitially, and threatened bare-metal vessel stents closure were used with as pl aain bail-out old balloon intervention angioplasty. scenario However, in the case the ofreported abrupt positive and threatened outcomes vessel encouraged closure withstent plain placement old balloon to be adopted angioplasty. as the However, standard the of reportedcare in percutaneous positive outcomes coronary encouraged intervention stent (PCI) placement [22]. Regardless to be adopted of the as history the standard of clinical of caresafety in and percutaneous efficacy, the coronary usage of intervention the first gene (PCI)ration [22 of]. these Regardless devices of was the frequently history of clinicallimited safetyby in-stent and efficacy,restenosis, the resulting usage of thein the first failure generation of the ofexisting these devicesstent or wasa reintervention frequently limited using byanother in-stent stent restenosis, [20]. resulting in the failure of the existing stent or a reintervention using anotherYears stent later, [20 as]. a solution to these issues, the deployment of drug-eluting stents (DESs) becameYears an later, integral as a solutiontreatment to theseoption issues, for patients the deployment with coronary of drug-eluting artery stentsdisease (DESs) [23]. becameCoronary an DESs integral not treatmentonly revolutionized option for PCI patients treatment with coronarybut have also artery been disease approved [23]. Coro-as the narycurrent DESs standard not only as they revolutionized significantly PCI reduce treatment restenosis but of have vascular also beenstents approved and mitigate as thethe currentneed for standard repeat revascularizations as they significantly [20,24,25]. reduce restenosis of vascular stents and mitigate the needThe for repeatdecades revascularizations of research and clinical [20,24,25 trials]. in this field have resulted in various stent designsThe involving decades of diverse research materials, and clinical from trials which in this doctors field have can resultedchoose the in various appropriate stent designsdevice depending involving diverseon the local materials, deposition from whichof plaque doctors and canfatty choose substances the appropriate and the potential device dependingside effects on[15,18]. the local deposition of plaque and fatty substances and the potential side effectsThis [15 ,paper18]. thus aims to review past and currently available stents and shed some light Thison how paper these thus devices aims tocan review be further past optimized and currently towards available ideal stentsin vivo and behavior. shed some light on how these devices can be further optimized towards ideal in vivo behavior. 2. Evolution of Cardiovascular Stents 2. Evolution of Cardiovascular Stents The rapid technological advancements that have taken place over the past 40 years The rapid technological advancements that have taken place over the past 40 years have greatlygreatly affectedaffected PCIPCI evolutionevolution [26[26].]. InterventionalInterventional cardiologycardiology hashas undoubtedlyundoubtedly evolved since thethe firstfirst percutaneouspercutaneous transluminaltransluminal coronarycoronary angioplasty.angioplasty. ThisThis evolutionevolution began with a balloonballoon cathetercatheter mounted on a fixedfixed wirewire andand progressedprogressed intointo bare-metalbare-metal stents (BMSs),(BMSs), first-generationfirst-generation DESs,DESs, andand second-second- andand third-generationthird-generation biodegradablebiodegradable polymer-basedpolymer-based DESs,DESs, culminatingculminating inin thethe introductionintroduction ofof bioresorbablebioresorbable vascularvascular scaffoldsscaffolds (BVSs),(BVSs), whichwhich areare currentlycurrently underunder developmentdevelopment [[7,17]7,17] (Figure(Figure1 ).1). FigureFigure 1. 1. CardiovascularCardiovascular stents stents evolution—a evolution—a brief brief timeline. timeline. Create Createdd based based on oninformation information from from the theliterature literature [7,27–29]. [7,27–29 ]. Stents s were found to have versatile medical applications (Figure(Figure2 2)) in in a a wide wide variety variety of clinical emergencies after after their their introduction introduction by by Charles Charles Theodore Theodore Dotter
Recommended publications
  • Coding for Angioplasty & Stent Procedures
    Coding for Angioplasty & Stent Procedures July 2020 Jennifer Bash, RHIA, CIRCC, RCCIR, CPC, RCC Director of Coding Education Agenda • Introduction • Definitions • General Coding Guidelines • Presenting Problems/Medical Necessity for Angioplasty & Stent • General Angioplasty & Stent Procedures • Cervicocerebral Procedures • Lower Extremity Procedures Disclaimer The information presented is based on the experience and interpretation of the presenters. Though all of the information has been carefully researched and checked for accuracy and completeness, ADVOCATE does not accept any responsibility or liability with regard to errors, omissions, misuse or misinterpretation. CPT codes are trademark and copyright of the American Medical Association. Resources •AMA •CMS • ACR/SIR • ZHealth Publishing Angioplasty & Stent Procedures Angioplasty Angioplasty, also known as balloon angioplasty and percutaneous transluminal angioplasty, is a minimally invasive endovascular procedure used to widen narrowed or obstructed arteries or veins, typically to treat arterial atherosclerosis. Vascular Stent A stent is a tiny tube placed into the artery or vein used to treat vessel narrowing or blockage. Most stents are made of a metal or plastic mesh-like material. General Angioplasty & Stent Coding Guidelines • Angioplasty is not separately billable when done with a stent • Pre-Dilatation • PTA converted to Stent • Prophylaxis • EXCEPTION-Complication extending to a different vessel • Coded per vessel • Codes include RS&I • Territories • Hierarchy General Angioplasty
    [Show full text]
  • Coronary Angiogram, Angioplasty and Stent Placement
    Page 1 of 6 Coronary Angiogram, Angioplasty and Stent Placement A Patient’s Guide Page 2 of 6 What is coronary artery disease? What is angioplasty and a stent? Coronary artery disease means that you have a If your doctor finds a blocked artery during your narrowed or blocked artery. It is caused by the angiogram, you may need an angioplasty (AN-jee- buildup of plaque (fatty material) inside the artery o-plas-tee). This is a procedure that uses a small over many years. This buildup can stop blood from inflated balloon to open a blocked artery. It can be getting to the heart, causing a heart attack (the death done during your angiogram test. of heart muscle cells). The heart can then lose some of its ability to pump blood through the body. Your doctor may also place a stent at this time. A stent is a small mesh tube that is placed into an Coronary artery disease is the most common type of artery to help keep it open. Some stents are coated heart disease. It is also the leading cause of death for with medicine, some are not. Your doctor will both men and women in the United States. For this choose the stent that is right for you. reason, it is important to treat a blocked artery. Angioplasty and stent Anatomy of the Heart 1. Stent with 2. Balloon inflated 3. Balloon balloon inserted to expand stent. removed from into narrowed or expanded stent. What is a coronary angiogram? blocked artery. A coronary angiogram (AN-jee-o-gram) is a test that uses contrast dye and X-rays to look at the blood vessels of the heart.
    [Show full text]
  • Coronary Artery Perforation
    Published online: 2019-09-20 THIEME 110 InterventionalCoronary Artery Rounds Perforation Deb et al. Coronary Artery Perforation Tripti Deb1 Jyotsna Maddury2 Prasant Kr. Sahoo3 1Department of Interventional Cardiology, Apollo Hospitals, Address for correspondence Jyotsna Maddury, MD, DM, FACC, Hyderabad, Telangana, India Department of Cardiology, Nizam’s Institute of Medical Sciences 2Department of Cardiology, Nizam’s Institute of Medical Sciences (NIMS), Punjagutta, Hyderabad, Telangana 500082, India (NIMS), Punjagutta, Hyderabad, India (e-mail: [email protected]). 3Department of Interventional Cardiology, Apollo Hospitals, Bhubaneswar, Odisha, India Ind J Car Dis Wom 2019;4:110–120 Abstract Percutaneous coronary intervention (PCI) is considered as the standard treatment of obstructive coronary artery disease in indicated patients. Even though PCI gives symp- Keywords tomatic angina improvement, but associated with serious complications like coronary ► coronary artery artery perforation (CAP), the incidence is quite low. With the more complex lesions for perforation successful angioplasty, different devices are required, which in turn increase the inci- ► percutaneous coro- dence of CAP in these patients. Here we review the classification, incidence, pathogen- nary intervention esis, clinical sequela, risk factors, predictors, and management of CAP in the current ► coronary artery era due to PCI. perforation ► management of coro- nary perfusion Introduction Consequences of Coronary Artery Perforation Percutaneous coronary intervention (PCI) for obstructive coronary artery diseases is accepted and has standardized Consequences of CAP depend on the location and severity. procedure with minimal complication rates, including iat- Location wise, if CAP occurs to the right or left ventricle, if not rogenic coronary artery perforation (CAP). Although angio- massive, then usually no immediate clinical consequences graphically significant coronary artery dissection is known occur.
    [Show full text]
  • Case Report Long-Term Results of Vascular Stent Placements for Portal Vein Stenosis Following Liver Transplantation
    Int J Clin Exp Med 2017;10(3):5514-5520 www.ijcem.com /ISSN:1940-5901/IJCEM0042813 Case Report Long-term results of vascular stent placements for portal vein stenosis following liver transplantation Yue-Lin Zhang1,2, Chun-Hui Nie1,2, Guan-Hui Zhou1,2, Tan-Yang Zhou1,2, Tong-Yin Zhu1,2, Jing Ai3, Bao-Quan Wang1,2, Sheng-Qun Chen1,2, Zi-Niu Yu1,2, Wei-Lin Wang1,2, Shu-Sen Zheng1,2, Jun-Hui Sun1,2 1Department of Hepatobiliary and Pancreatic Interventional Center, The First Affiliated Hospital, School of Medi- cine, Zhejiang University, Hangzhou 310003, Zhejiang Province, China; 2Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, Hangzhou 310003, Zhejiang Province, China; 3Department of Oph- thalmology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, Zhejiang Province, China Received October 25, 2016; Accepted January 4, 2017; Epub March 15, 2017; Published March 30, 2017 Abstract: Portal vein stenosis (PVS) is a serious complication after liver transplantation (LT) and can cause in- creased morbidity, graft loss, and patient death. The aim of this study was to evaluate the long-term treatment ef- fect of vascular stents in the management of PVS after LT. In the present study, follow-up data on 16 patients who received vascular stents for PVS after LT between July 2011 and May 2015 were analyzed. Of these, five patients had portal hypertension-related signs and symptoms. All procedures were performed with direct puncture of the intrahepatic portal vein and with subsequent stent placement. Embolization was required for significant collateral circulation.
    [Show full text]
  • 3Rd Quarter 2001 Bulletin
    In This Issue... Promoting Colorectal Cancer Screening Important Information and Documentaion on Promoting the Prevention of Colorectal Cancer ....................................................................................................... 9 Intestinal and Multi-Visceral Transplantation Coverage Guidelines and Requirements for Approval of Transplantation Facilities12 Expanded Coverage of Positron Emission Tomography Scans New HCPCS Codes and Coverage Guidelines Effective July 1, 2001 ..................... 14 Skilled Nursing Facility Consolidated Billing Clarification on HCPCS Coding Update and Part B Fee Schedule Services .......... 22 Final Medical Review Policies 29540, 33282, 67221, 70450, 76090, 76092, 82947, 86353, 93922, C1300, C1305, J0207, and J9293 ......................................................................................... 31 Outpatient Prospective Payment System Bulletin Devices Eligible for Transitional Pass-Through Payments, New Categories and Crosswalk C-codes to Be Used in Coding Devices Eligible for Transitional Pass-Through Payments ............................................................................................ 68 Features From the Medical Director 3 he Medicare A Bulletin Administrative 4 Tshould be shared with all General Information 5 health care practitioners and managerial members of the General Coverage 12 provider/supplier staff. Hospital Services 17 Publications issued after End Stage Renal Disease 19 October 1, 1997, are available at no-cost from our provider Skilled Nursing Facility
    [Show full text]
  • ICD~10~PCS Complete Code Set Procedural Coding System Sample
    ICD~10~PCS Complete Code Set Procedural Coding System Sample Table.of.Contents Preface....................................................................................00 Mouth and Throat ............................................................................. 00 Introducton...........................................................................00 Gastrointestinal System .................................................................. 00 Hepatobiliary System and Pancreas ........................................... 00 What is ICD-10-PCS? ........................................................................ 00 Endocrine System ............................................................................. 00 ICD-10-PCS Code Structure ........................................................... 00 Skin and Breast .................................................................................. 00 ICD-10-PCS Design ........................................................................... 00 Subcutaneous Tissue and Fascia ................................................. 00 ICD-10-PCS Additional Characteristics ...................................... 00 Muscles ................................................................................................. 00 ICD-10-PCS Applications ................................................................ 00 Tendons ................................................................................................ 00 Understandng.Root.Operatons..........................................00
    [Show full text]
  • Ventricular Long Axis Function: Amplitudes and Timings
    Umeå University Medical Dissertations New Series No 895 - ISSN 0346-6612 _______________________________________________________________ From the Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden Ventricular Long Axis Function: Amplitudes and Timings Echocardiographic Studies in Health and Disease Frederick Bukachi Umeå 2004 © Copyright: Frederick Bukachi ISBN 91-7305-661-8 Printed in Sweden by Solfjädern offset AB Umeå, 2004 To my family Frida, Anthony, Arnold and Maria Time brings wisdom to the mind and healing to the heart. Anonymous Table of contents Table of contents................................................................................................................. 1 Abstract ................ ............................................................................................................. 3 List of original studies ........................................................................................................4 Abbreviations...................................................................................................................... 5 1. Introduction............................................................................................................. 6 2. Ventricular long axis ............................................................................................... 6 2.1. General overview and historical perspective................................................ 6 2.2. Anatomy of long axis ..................................................................................
    [Show full text]
  • TAXUS™ Express 2 ™ Paclitaxel-Eluting
    TAXU S ® Express 2® Paclitaxel-Eluting Coronary Stent System Patient Information Guide Table of Contents Notes Coronary Artery Disease . 2 Who is at Risk? . .3 Diagnosis of Coronary Artery Disease . 3 Treatment of Coronary Artery Disease . 3 Angioplasty . 4 Coronary Artery Stents . 4 Restenosis . 5 Your Drug-Eluting Stent, the TAXUS ® Express 2® Paclitaxel-Eluting Coronary Stent System . 7 Drug-Eluting Stents . 7 The Express ® Stent Platform for the TAXUS ® Express ® Stent . 7 The Polymer Coating on the TAXUS Express Stent . 7 The Drug that is Released from the TAXUS Express Stent . 8 When should the TAXUS Express Stent NOT be Used . 8 What are the Risks & Potential Benefits of Treatment with the TAXUS Express Stent? . 9 Alternative Practices and Procedures . 11 The Angioplasty Procedure . 12 Preparation for the Procedure . 12 Angioplasty and Stent Placement Procedure . 12 Post-Treatment . 13 After the Procedure . 13 Activity . 14 Medications . 14 Follow-Up Examinations . 15 Magnetic Resonance Imaging (MRI) . 15 Frequently Asked Questions . 16 Glossary . 17 Patient Information Card . Inside Back Cover 1 Notes Coronary Artery Disease Coronary Artery Disease (CAD) is usually caused by atherosclerosis, and affects the coronary arteries that surround the heart. These coronary arteries supply blood with oxygen and other nutrients to the heart muscle to make it function properly. CAD occurs when the inner walls of the coronary arteries thicken due to a buildup of cholesterol, fatty deposits, calcium, and other elements. This material is known as plaque. As plaque develops, the vessel narrows. When the vessel narrows (for example with physical exertion or mental stress), Aorta blood flow through the vessel is reduced so less oxygen and Right Left other nutrients reach Coronary Coronary the heart muscle.
    [Show full text]
  • Clinical Appropriateness Guidelines: Percutaneous Coronary Intervention
    Clinical Appropriateness Guidelines: Percutaneous Coronary Intervention Appropriate Use Criteria Effective Date: January 2, 2018 Proprietary Date of Origin: 08/27/2015 Last revised: 08/01/2017 Last reviewed: 09/07/2017 8600 W Bryn Mawr Avenue South Tower - Suite 800 Chicago, IL 60631 P. 773.864.4600 Copyright © 2018. AIM Specialty Health. All Rights Reserved www.aimspecialtyhealth.com Table of Contents Description and Application of the Guidelines ........................................................................3 Percutaneous Coronary Intervention .......................................................................................4 Table of Contents | Copyright © 2018. AIM Specialty Health. All Rights Reserved. 2 Description and Application of the Guidelines AIM’s Clinical Appropriateness Guidelines (hereinafter “AIM’s Clinical Appropriateness Guidelines” or the “Guidelines”) are designed to assist providers in making the most appropriate treatment decision for a specific clinical condition for an individual. As used by AIM, the Guidelines establish objective and evidence-based, where possible, criteria for medical necessity determinations. In the process, multiple functions are accomplished: ● To establish criteria for when services are medically necessary ● To assist the practitioner as an educational tool ● To encourage standardization of medical practice patterns ● To curtail the performance of inappropriate and/or duplicate services ● To advocate for patient safety concerns ● To enhance the quality of healthcare ● To promote the most efficient and cost-effective use of services AIM’s guideline development process complies with applicable accreditation standards, including the requirement that the Guidelines be developed with involvement from appropriate providers with current clinical expertise relevant to the Guidelines under review and be based on the most up to date clinical principles and best practices. Relevant citations are included in the “References” section attached to each Guideline.
    [Show full text]
  • Everolimus Eluting Coronary Stent System
    Everolimus Eluting Coronary Stent System Patient Information Guide Table of Contents Coronary Artery Disease (CAD) ........................5 Your Drug-Eluting Stent Procedure ................19 Your Heart ........................................................5 How Do I Prepare for My Procedure? ...........19 What is CAD? ..................................................5 Your Drug-Eluting Stent Placement What are the Symptoms of CAD? ...................5 Procedure ......................................................19 What are the Risk Factors of CAD? ................6 Immediately after Procedure .........................22 How Can My Doctor Tell if I Have CAD? .........7 Take All Medications as Instructed ................22 Follow-up Care ..............................................23 Your Treatment Options .....................................8 Keep Your ID Card Handy .............................23 Surgery .............................................................9 Angioplasty ......................................................9 Preventing CAD ................................................24 Coronary Artery Stents ..................................10 Frequently Asked Questions ...........................25 Drug-Eluting Stents (DES) ...............................11 Definition of Medical Terms ............................26 XIENCE Family of Coronary Stents ................12 Contraindications ...........................................13 Potential Adverse Events Associated with the XIENCE Family of Coronary Stents ..........13
    [Show full text]
  • Pericardial Bleeding Following Covered Stent Thrombosis: Sharp Blade on Both Sides
    CASE REPORT Acta Medica Alanya 2018;2(3): 210-214 OLGU SUNUMU DOI: 10.30565/ medalanya.421746 Pericardial Bleeding Following Covered Stent Thrombosis: Sharp Blade on Both Sides Kaplı Stent Trombozu Sonrası Perikardiyal Kanama: İki Ucu Keskin Bıçak Ali Çoner1*, Davran Çiçek1, Sinan Akıncı1, Tonguç Saba2, Haldun Müderrisoğlu3 1.Department of Cardiology, Başkent University Alanya Education and Research Center, Alanya, Turkey 2.Department of Cardiovascular Surgery, Başkent University, Education and Research Center, Alanya, Turkey 3.Department of Cardiology, Başkent University Hospital, Ankara, Turkey ABSTRACT ÖZ Advancements in coronary stent technology encourage interventional cardiologists Koroner stent alanındaki teknolojik gelişmeler girişimsel kardiyologları daha kom- in performing more complex, percutaneous interventions. Coronary perforation is pleks perkütan girişimler gerçekleştirme konusunda cesaretlendirmektedir. Koroner a lethal complication of percutaneous coronary artery interventions and should be perforasyon perkütan koroner arter girişimleri esnasında görülebilen ölümcül bir managed within seconds to minutes. Despite technological advancements, coronary komplikasyondur ve saniyeler veya dakikalar içerisinde müdahale edilmelidir. perforation incidence has not declined over the years. This consistent incidence of Geçen yıllar içerisinde teknolojik gelişmeler olmasına karşın koroner perforasyon coronary perforation may be related to increased number of complex, percutaneous sıklığı azalmamıştır. Koroner perforasyon sıklığında
    [Show full text]
  • Electrocardiogram-Gated Intravascular Ultrasound Image
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Erasmus University Digital Repository 436 JACC Vol. 30, No. 2 August 1997:436–43 INTERVENTIONAL CARDIOLOGY Electrocardiogram-Gated Intravascular Ultrasound Image Acquisition After Coronary Stent Deployment Facilitates On-Line Three-Dimensional Reconstruction and Automated Lumen Quantification CLEMENS VON BIRGELEN, MD,* GARY S. MINTZ, MD, FACC,† ANTONINO NICOSIA, MD, DAVID P. FOLEY, MB, MRCPI, PHD, WIM J. VAN DER GIESSEN, MD, PHD, NICO BRUINING, BSC, SERGEI G. AIRIIAN, MD, JOS R. T. C. ROELANDT, MD, PHD, FACC, PIM J. DE FEYTER, MD, PHD, FACC, PATRICK W. SERRUYS, MD, PHD, FACC Rotterdam, The Netherlands and Washington, D.C. Objectives. This study evaluates the feasibility, reliability and correlated closely (r >2 0.95), and the minimal stent lumen differed reproducibility of electrocardiogram (ECG)-gated intravascular only minimally (8.6 6 2.8 mm2 vs. 8.5 6 2.8 mm2,p5NS). The ultrasound (IVUS) image acquisition during automated trans- conventional analysis significantly overestimated the minimal ducer withdrawal and automated three-dimensional (3D) bound- stent lumen (9.0 6 2.7 mm2, p < 0.005) in comparison with results ary detection for assessing on-line the result of coronary stenting. of both 3D analyses. Fourteen stents (41%) failed to meet the Background. Systolic-diastolic image artifacts frequently limit criteria by both 3D analyses, all of these not reaching optimal the clinical applicability of such automated analysis systems. expansion, but only 7 (21%) were detected by conventional anal- Methods. In 30 patients, after successful angiography-guided ysis (p < 0.02).
    [Show full text]